# Bioventus Inc.: Form 8-K, filed May 26, 2023

- Company: [Bioventus Inc.](/companies/bvs.md) (CIK 1665988)
- Form: 8-K
- Filed: 2023-05-26
- Accepted by EDGAR: May 26, 2023, 08:39 ET
- Period: 2023-05-22
- Accession: 0001628280-23-019872
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1665988/000162828023019872/bvs-20230522.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1665988/000162828023019872/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1665988/000162828023019872/bvs-20230522.htm

Filed May 26, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-019872. Last ingested by Listed: Nov 2, 2026, 17:44 ET. No prices; not investment advice.